跳至主要内容
临床试验/NCT07199309
NCT07199309招募中2 期

Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of MAR001 on Postprandial Lipids in Patients With Elevated Triglycerides and Remnant Cholesterol

Marea Therapeutics1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年9月26日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
Change from baseline in TG area under the curve after a mixed meal

研究概览

简要总结

The primary objective of the study is to determine the effect of MAR001 as compared to placebo on levels of the triglycerides (TG) in the postprandial state in adults with elevated TG.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willingness to provide informed consent and comply with the intervention and all study assessments
  • Two fasting TG collected at two separate, consecutive visits at least 7 days apart during the Screening period
  • HbA1c ≥ 5.7% and ≤ 8.5%
  • Stable diet for a minimum of 3 months prior to screening and with no plans to change diet through duration of study
  • Stable drug regimen (appropriate if relevant) prior to screening visit and no planned changes during screening or trial participation

排除标准

  • Acute or chronic liver disease
  • Diabetes medications (other than metformin)
  • History of type 1 diabetes mellitus or history of diabetic ketoacidosis
  • Newly diagnosed T2DM
  • Participants with known active hepatitis A, B, or C
  • Participants who are known to have uncontrolled human immunodeficiency virus (HIV) infection
  • Uncontrolled hypothyroidism
  • Any condition that prevents the participant from complying with study procedures

研究组 & 干预措施

MAR001 Dose

Experimental

Subcutaneous Injection

干预措施: MAR001 (Drug)

Matching Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Change from baseline in TG area under the curve after a mixed meal

时间窗: 12 weeks

Change from baseline in peak plasma TG concentration after a mixed meal

时间窗: 12 weeks

次要结局

  • Change from baseline in RC area under the curve after a mixed meal(12 weeks)
  • Change from baseline in peak plasma RC concentration after a mixed meal(12 weeks)

研究者

发起方
Marea Therapeutics
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Mechanistic Study of MAR001 in Adults With... | 临床试验